Tg Therapeutics reported $22.5M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Amgen AMGN:US USD 1.47B 181M
Ardelyx ARDX:US USD 19.73M 1.06M
Arrowhead Research ARWR:US USD 22.65M 8.97M
Bayer BAYN:GR EUR 4.43B 347M
Biogen BIIB:US USD 632.8M 69.5M
Corcept Therapeutics CORT:US USD 42.32M 7.16M
Curis CRIS:US USD 4.33M 226K
Dynavax Technologies DVAX:US USD 30.38M 1.22M
Gilead Sciences GILD:US USD 2.02B 807M
Infinity Pharmaceuticals INFI:US USD 3.5M 6K
Intercept Pharmaceuticals ICPT:US USD 55.29M 12.02M
Johnson & Johnson JNJ:US USD 6.51B 423M
Karyopharm Therapeutics KPTI:US USD 34.65M 4K
Novartis NOVN:VX USD 3.7B 295M
Novavax NVAX:US USD 161.66M 38.79M
Ptc Therapeutics PTCT:US USD 92.72M 12.6M
Puma Biotechnology PBYI:US USD 25.04M 1.08M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 6.48B 834M
Spectrum Pharmaceuticals SPPI:US USD 8.26M 1.12M
Tg Therapeutics TGTX:US USD 22.5M 8.25M
Verastem VSTM:US USD 6.11M 315K
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
Ziopharm Oncology ZIOP:US USD 2.92M 357K